The CD47 “don't eat me signal” is highly expressed in human ovarian cancer
Authors:
- 1 November 2016
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 143 (2) , 393-397
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research Institute
- Ludwig Institute for Cancer Research
- Ovarian Cancer Research Fund
- Roswell Park Alliance Foundation
- NCI (P30 CA016056)
- NIH (1R01CA158318-01A1)
- RPCI-UPCI (P50CA159981-01A1)
- NYSTEM (N14C-002)
This publication has 14 references indexed in Scilit:
- LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer modelOncotarget, 2015
- CD47 protein expression in acute myeloid leukemia: A tissue microarray-based analysisLeukemia Research, 2015
- Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell CarcinomaInternational Journal of Molecular Sciences, 2015
- CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and DiseaseISRN Hematology, 2013
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsProceedings of the National Academy of Sciences, 2012
- Early T Cell Signalling Is Reversibly Altered in PD-1+ T Lymphocytes Infiltrating Human TumorsPLOS ONE, 2011
- Tumor-infiltrating NY-ESO-1–specific CD8 + T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancerProceedings of the National Academy of Sciences, 2010
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid PhagocytosisCell, 2009
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalNature Medicine, 2004
- Role of CD47 in Erythroid Cells and in AutoimmunityLeukemia & Lymphoma, 2004